SB 269970

CAS : 201038-74-6

Ref. 3D-BIA03874

Informations sur le produit

• Nom: SB 269970
• Synonymes: (2R)-1-[(3-Hydroxyphenyl)sulfonyl]-2-(2-(4-methyl-1-piperidinyl)ethyl)pyrrolidine, 3-[(2R)-2-[2-(4-Methylpiperidin-1-yl)ethyl]pyrrolidin-1-yl]sulfonylphenol, 3-[[(2R)-2-[2-(4-Methyl-1-piperidinyl)ethyl]-1-pyrrolidinyl]sulfonyl]phenol, Phenol, 3-[[(2R)-2-[2-(4-methyl-1-piperidinyl)ethyl]-1-pyrrolidinyl]sulfonyl]-, Phenol, 3-[[(2R)-2-[2-(4-methyl-1-piperidinyl)ethyl]-1-pyrrolidinyl]sulfonyl]-, hydrochloride (1:1), Pyrrolidine, 1-[(3-hydroxyphenyl)sulfonyl]-2-[2-(4-methyl-1-piperidinyl)ethyl]-, (2R)-, Pyrrolidine, 1-[(3-hydroxyphenyl)sulfonyl]-2-[2-(4-methyl-1-piperidinyl)ethyl]-, (R)-, Sb 269970, Sb269970

Description

SB 269970 is a pharmacological agent that binds to the 5-HT2 receptor. This drug has been shown to inhibit the proliferation of tumor cells in a mouse model and to reduce the release of 5-HT from trigeminal nerve endings. SB 269970 inhibits 5-HT2 receptors and blocks their activity. It also inhibits the synthesis of 5-HT, which is mediated by protein kinase C (PKC). SB 269970 has been shown to be an antagonist of growth factor β1 and can be used for the treatment of depression. This drug also has effects on microdialysis probes in rats, inhibiting 5-ht concentrations in whole cell recordings.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 352.49 g/mol
• Formule: C₁₈H₂₈N₂O₃S
• Degré de pureté: Min. 95%